戻る
Novo Nordisk A/S (NVO)価格
NVO 株価推移チャート
NVO 収入
Novo Nordisk A/S
$60.67
-2.66%
$-1.65
終値： Jan 20, 16:00:00 GMT-5
$60.7
0.04%
$0.03
アフターマーケット：Jan 20, 16:47:17 GMT-5
主要データ
前終値
$62.33
始値
$60.21
当日レンジ
$59.95 - $62.17
52週レンジ
$43.08 - $93.8
取引高
29.6M
平均取引高
19.1M
1株当たり利益(TTM)
3.67
配当利回り
--
時価総額
$204.4B
NVOとは何ですか？
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.